We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Welltower Stock Gains 19.4% in 6 Months: Will it Continue to Rise?
Read MoreHide Full Article
Key Takeaways
WELL shares rose 19.4% in six months, beating the industry's 2.9% gain over the same period.
WELL's seniors housing portfolio gains from aging demographics, rising healthcare spend and muted new supply.
WELL boosted growth via acquisitions, development funding and a strong balance sheet with $11.9B liquidity.
Shares of Welltower (WELL - Free Report) have gained 19.4% in the past six months, outperforming the industry’s upside of 2.9%.
This healthcare real estate investment trust (REIT) boasts a well-diversified portfolio of healthcare real estate assets in the key markets of the United States, Canada and the U.K.
Given an aging population and an expected rise in senior citizens’ healthcare expenditure, its seniors housing operating portfolio (SHOP) is well-poised to experience solid demand. The outpatient medical (OM) segment is expected to gain from the favorable outpatient visit trends in the near term. Its strategic restructuring initiatives have enabled it to attract top-class operators and improve cash flows.
Image Source: Zacks Investment Research
Let us decipher the possible factors behind the surge in the stock price for this Zacks Rank #3 (Hold) company.
The national healthcare expenditure by senior citizens, who constitute a major customer base of healthcare services and incur higher healthcare expenditures than the average population, is likely to increase in the upcoming period. Muted new supply has also been a tailwind for this industry. Given these circumstances, Welltower’s SHO portfolio remains well-poised to capitalize on this positive trend.
There has been a favorable outpatient visit trend compared with inpatient admissions. Given the favorable secular trends and growing need for value-based care, the company’s efforts to strengthen its OM footprint will boost long-term growth.
Welltower remains focused on improving its SHO portfolio through the addition of strategic properties and the recycling of capital through dispositions. From the beginning of the year through Oct. 27, 2025, Welltower completed $5.82 billion of pro-rata gross investments, including $5.47 billion in acquisitions and loan funding, and $351.1 million in development funding. The company has also been disposing of assets simultaneously. From the beginning of the year through Oct. 27, 2025, Welltower completed pro rata property dispositions of $438.8 million and loan repayments of $329.5 million.
Welltower has a healthy balance sheet position and ample liquidity to meet near-term obligations and fund its development pipeline. As of Sept. 30, 2025, it had $11.9 billion of available liquidity, including $6.9 billion of cash and restricted cash and full capacity under its $5 billion line of credit. As of Sept. 30, 2025, the net debt to adjusted EBITDA was 2.36X. Moreover, Welltower’s debt maturities are well-laddered, with a weighted average maturity of 5.7 years, enhancing its financial flexibility.
Key Risks for WELL
A competitive landscape in the senior housing market and tenant concentration in its triple-net portfolio are likely to weigh on Welltower. A substantial debt burden adds to its concerns.
The Zacks Consensus Estimate for DLR’s 2025 and 2026 FFO per share is pinned at $7.35 and $7.91, respectively. This indicates year-over-year growth of 9.5% for 2025 and 7.6% for 2026.
The Zacks Consensus Estimate for PLD’s 2025 and 2026 FFO per share is pegged at $5.80 and $6.08, respectively. This implies year-over-year growth of 4.3% for 2025 and 4.7% for 2026.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Welltower Stock Gains 19.4% in 6 Months: Will it Continue to Rise?
Key Takeaways
Shares of Welltower (WELL - Free Report) have gained 19.4% in the past six months, outperforming the industry’s upside of 2.9%.
This healthcare real estate investment trust (REIT) boasts a well-diversified portfolio of healthcare real estate assets in the key markets of the United States, Canada and the U.K.
Given an aging population and an expected rise in senior citizens’ healthcare expenditure, its seniors housing operating portfolio (SHOP) is well-poised to experience solid demand. The outpatient medical (OM) segment is expected to gain from the favorable outpatient visit trends in the near term. Its strategic restructuring initiatives have enabled it to attract top-class operators and improve cash flows.
Image Source: Zacks Investment Research
Let us decipher the possible factors behind the surge in the stock price for this Zacks Rank #3 (Hold) company.
The national healthcare expenditure by senior citizens, who constitute a major customer base of healthcare services and incur higher healthcare expenditures than the average population, is likely to increase in the upcoming period. Muted new supply has also been a tailwind for this industry. Given these circumstances, Welltower’s SHO portfolio remains well-poised to capitalize on this positive trend.
There has been a favorable outpatient visit trend compared with inpatient admissions. Given the favorable secular trends and growing need for value-based care, the company’s efforts to strengthen its OM footprint will boost long-term growth.
Welltower remains focused on improving its SHO portfolio through the addition of strategic properties and the recycling of capital through dispositions. From the beginning of the year through Oct. 27, 2025, Welltower completed $5.82 billion of pro-rata gross investments, including $5.47 billion in acquisitions and loan funding, and $351.1 million in development funding. The company has also been disposing of assets simultaneously. From the beginning of the year through Oct. 27, 2025, Welltower completed pro rata property dispositions of $438.8 million and loan repayments of $329.5 million.
Welltower has a healthy balance sheet position and ample liquidity to meet near-term obligations and fund its development pipeline. As of Sept. 30, 2025, it had $11.9 billion of available liquidity, including $6.9 billion of cash and restricted cash and full capacity under its $5 billion line of credit. As of Sept. 30, 2025, the net debt to adjusted EBITDA was 2.36X. Moreover, Welltower’s debt maturities are well-laddered, with a weighted average maturity of 5.7 years, enhancing its financial flexibility.
Key Risks for WELL
A competitive landscape in the senior housing market and tenant concentration in its triple-net portfolio are likely to weigh on Welltower. A substantial debt burden adds to its concerns.
Stocks to Consider
Some better-ranked stocks from the broader REIT sector are Digital Realty Trust (DLR - Free Report) and Prologis (PLD - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for DLR’s 2025 and 2026 FFO per share is pinned at $7.35 and $7.91, respectively. This indicates year-over-year growth of 9.5% for 2025 and 7.6% for 2026.
The Zacks Consensus Estimate for PLD’s 2025 and 2026 FFO per share is pegged at $5.80 and $6.08, respectively. This implies year-over-year growth of 4.3% for 2025 and 4.7% for 2026.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.